NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

Core Insights - NeuroOne Medical Technologies Corporation has received a notice of allowance for a key patent related to neural probe technologies, which is expected to enhance its intellectual property portfolio [1][2] - The patent covers novel methods for making neural probe devices, including specific arrangements of probe components and deposition of electrode contact material [1][3] - The company currently holds 17 issued and pending patents in the U.S. and internationally, focusing on thin-film electrode technologies for neural and spinal cord applications [3] Company Overview - NeuroOne is focused on developing minimally invasive and high-definition solutions for various neurological disorders, including epilepsy, Parkinson's disease, and chronic pain [4] - The company aims to improve patient outcomes and reduce procedural costs while exploring applications in other areas such as depression and artificial intelligence [4]